Necroptosis induction contributes to suppressing therapeutic resistance in cancer stem cells [27–29], thus we evaluated whether the identified targets WT1 and FOXA1, which have an impact on stemness by targeting AR, could also play a role in necroptosis activation. Here, FOXA1 is linked to cancer.